0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight pulmonary arterial hypertension epidemiology forecast 2027.Your search for "" gave back 1515167 results.
The “Respiratory Inhaler Devices Industry Forecast” looks at past sales and reviews total world Respiratory Inhaler Devices sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Pulmonary Hypertension Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Pulmonary...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Pulmonary Hypertension Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Pulmonary Hypertension Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Primary Pulmonary Hypertension (PPH) Treatment market size was valued at US$ million in 2022. With growing demand in downstream market,...
Catalog:
LPI
December 2023
Price: USD 3,660.00
Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018 Summary Plasminogen...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Pulmonary Hypertension Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Chronic Pulmonary Hypertension Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Chronic Pulmonary Hypertension Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Pulmonary Hypertension Drug Industry Forecast” looks at past sales and reviews total world Pulmonary Hypertension Drug sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
According to our publisher latest study, the global Pulmonary Hypertension Treatment market size was valued at USD million in 2022 and is forecast to...
Catalog:
GIR
March 2023
Price: USD 3,480.00
